When was MEDIX Laboratoires N.V founded?

MEDIX Laboratoires N.V was founded on 18 Dec 2013, making it 12 years old.

Is MEDIX Laboratoires N.V still active?

Yes, MEDIX Laboratoires N.V is currently active.

Where is MEDIX Laboratoires N.V registered?

MEDIX Laboratoires N.V's registered address is Industriepark "De Bruwaan" 25, 9700 Oudenaarde, Belgium.

How many employees does MEDIX Laboratoires N.V have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), MEDIX Laboratoires N.V reported 65.1 full-time equivalent employees.

What is MEDIX Laboratoires N.V's annual turnover?

MEDIX Laboratoires N.V's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €45,750,491.

Did MEDIX Laboratoires N.V make a profit or a loss?

MEDIX Laboratoires N.V's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €2,508,973.

When did MEDIX Laboratoires N.V last file annual accounts?

MEDIX Laboratoires N.V's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is MEDIX Laboratoires N.V B Corp certified?

We have no B Corp certification on file for MEDIX Laboratoires N.V.

Does MEDIX Laboratoires N.V hold Fairtrade certification?

No, MEDIX Laboratoires N.V does not currently hold Fairtrade certification.

MEDIX Laboratoires N.V

Q: What does MEDIX Laboratoires N.V do?

MEDIX Laboratoires N.V's registered main activities are Manufacture of other food products n.e.c., Manufacture of homogenised food preparations and dietetic food, Other non-specialised retail sale, and Other non-specialised wholesale trade of food products. It is also registered for 1 additional activity.

BE 0543.388.753

Copied!

NV/SA

Status

Active

Founded

18 Dec 2013 · 12 yrs

Size

Medium · 65.1 FTE

Legal name

MEDIX Laboratoires

Main activity

Manufacture of other food products n.e.c.

Website

medixlaboratoires.eu

Activities

5 activities

Manufacture of other food products n.e.c.Manufacture of homogenised food preparations and dietetic foodOther non-specialised retail saleOther non-specialised wholesale trade of food productsWholesale of other food n.e.c.

Financials

Turnover2025

€45.8M+29.4%

Profit / Loss2025

€2.5M+63.8%

Equity2025

€4.2M+151.9%

2025	2024	2023	2022
€45,750,491+29.4%	€35,353,029+12.9%	€31,316,998+65.4%	€18,930,134
€2,508,973+63.8%	€1,531,618+16%	€1,320,097+190%	-€1,466,998
€4,160,235+151.9%	€1,651,262>1000%	€119,644+110%	-€1,200,453
€16,435,584+38.8%	€11,838,909-20.1%	€14,814,752+10.9%	€13,356,794
€1,107,087-58.4%	€2,660,775+130.5%	€1,154,411+835.5%	€123,395
65.1+12.8%	57.7+39.4%	41.4+18.3%	35
€702,773+14.7%	€612,704-19%	€756,449+39.9%	€540,861

Frequently asked questions

01What is MEDIX Laboratoires N.V's official registered name?

MEDIX Laboratoires.

02What is MEDIX Laboratoires N.V's enterprise number (VAT number)?

BE 0543.388.753.

03What is MEDIX Laboratoires N.V's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€45,750,491+29.4%	€35,353,029+12.9%	€31,316,998+65.4%	€18,930,134
	€4,332,361+18.2%	€3,666,339+43%	€2,563,271+26.2%	€2,031,458
	€2,822,207+88.4%	€1,498,408-8.3%	€1,634,775+234.7%	-€1,213,504
	€3,581,638	—	—	—
	€2,508,973+63.8%	€1,531,618+16%	€1,320,097+190%	-€1,466,998
	€198,887+88.1%	€105,763+0.4%	€105,351+373.8%	€22,235
Profitability
	7.8%	—	—	—
	5.5%+26.6%	4.3%+2.8%	4.2%+154.4%	-7.7%
	60.3%-35%	92.8%-91.6%	1103.4%+802.9%	122.2%
	12.2%+7.3%	11.4%+28.4%	8.8%+173.3%	-12.1%
Solvency
	€20,595,819+52.7%	€13,490,171-9.7%	€14,934,396+22.9%	€12,156,341
	€3,375,105+34.7%	€2,506,033+10.1%	€2,277,058+7.7%	€2,114,084
	€39,424-17.9%	€48,008+3.2%	€46,519+15%	€40,461
	€4,160,235+151.9%	€1,651,262>1000%	€119,644+110%	-€1,200,453
	20.2%+65%	12.2%>1000%	0.8%+108.1%	-9.9%
	€5,172,108+5.2%	€4,918,741+13.8%	€4,322,480+38.9%	€3,111,793
	1.24-58.3%	2.98-91.7%	36.13>1000%	-2.59
	€16,435,584+38.8%	€11,838,909-20.1%	€14,814,752+10.9%	€13,356,794
	3.95-44.9%	7.17-94.2%	123.82>1000%	-11.13
	24.51+54.5%	15.86+19.8%	13.24+138.6%	-34.33
Liquidity
	€1,107,087-58.4%	€2,660,775+130.5%	€1,154,411+835.5%	€123,395
	€6,529,154+30.2%	€5,014,874-27.3%	€6,896,302+35.3%	€5,098,743
	€9,064,453+213.4%	€2,892,374-31.3%	€4,210,146-5.9%	€4,475,287
	€9,994,725+60.9%	€6,212,977-37.6%	€9,956,935+17.1%	€8,505,132
	€11,263,476+62.8%	€6,920,168-34%	€10,492,210+2.4%	€10,243,487
	1.41+20%	1.18+8.9%	1.08+13.2%	0.96
	€5,776,250+48.2%	€3,898,511+93%	€2,020,194+716.8%	-€327,541
Efficiency
	72 days+142.2%	30 days-39.1%	49 days-43.1%	86 days
	96 days+26.3%	76 days-43.8%	136 days-21.2%	172 days
	72 days+0.1%	72 days-36%	112 days-9.4%	124 days
	5.76+34.3%	4.29+14.4%	3.75+4.5%	3.59
Profit appropriation
	-€13,318,734+15.9%	-€15,827,707+8.8%	-€17,359,325+7.1%	-€18,679,422

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€45,750,491+29.4%	€35,353,029+12.9%	€31,316,998+65.4%	€18,930,134
	€4,332,361+18.2%	€3,666,339+43%	€2,563,271+26.2%	€2,031,458
	€2,822,207+88.4%	€1,498,408-8.3%	€1,634,775+234.7%	-€1,213,504
	€3,581,638	—	—	—
	€2,508,973+63.8%	€1,531,618+16%	€1,320,097+190%	-€1,466,998
	€198,887+88.1%	€105,763+0.4%	€105,351+373.8%	€22,235
Profitability
	7.8%	—	—	—
	5.5%+26.6%	4.3%+2.8%	4.2%+154.4%	-7.7%
	60.3%-35%	92.8%-91.6%	1103.4%+802.9%	122.2%
	12.2%+7.3%	11.4%+28.4%	8.8%+173.3%	-12.1%
Solvency
	€20,595,819+52.7%	€13,490,171-9.7%	€14,934,396+22.9%	€12,156,341
	€3,375,105+34.7%	€2,506,033+10.1%	€2,277,058+7.7%	€2,114,084
	€39,424-17.9%	€48,008+3.2%	€46,519+15%	€40,461
	€4,160,235+151.9%	€1,651,262>1000%	€119,644+110%	-€1,200,453
	20.2%+65%	12.2%>1000%	0.8%+108.1%	-9.9%
	€5,172,108+5.2%	€4,918,741+13.8%	€4,322,480+38.9%	€3,111,793
	1.24-58.3%	2.98-91.7%	36.13>1000%	-2.59
	€16,435,584+38.8%	€11,838,909-20.1%	€14,814,752+10.9%	€13,356,794
	3.95-44.9%	7.17-94.2%	123.82>1000%	-11.13
	24.51+54.5%	15.86+19.8%	13.24+138.6%	-34.33
Liquidity
	€1,107,087-58.4%	€2,660,775+130.5%	€1,154,411+835.5%	€123,395
	€6,529,154+30.2%	€5,014,874-27.3%	€6,896,302+35.3%	€5,098,743
	€9,064,453+213.4%	€2,892,374-31.3%	€4,210,146-5.9%	€4,475,287
	€9,994,725+60.9%	€6,212,977-37.6%	€9,956,935+17.1%	€8,505,132
	€11,263,476+62.8%	€6,920,168-34%	€10,492,210+2.4%	€10,243,487
	1.41+20%	1.18+8.9%	1.08+13.2%	0.96
	€5,776,250+48.2%	€3,898,511+93%	€2,020,194+716.8%	-€327,541
Efficiency
	72 days+142.2%	30 days-39.1%	49 days-43.1%	86 days
	96 days+26.3%	76 days-43.8%	136 days-21.2%	172 days
	72 days+0.1%	72 days-36%	112 days-9.4%	124 days
	5.76+34.3%	4.29+14.4%	3.75+4.5%	3.59
Profit appropriation
	-€13,318,734+15.9%	-€15,827,707+8.8%	-€17,359,325+7.1%	-€18,679,422

2025

2024

2023

2022

Income statement

€45,750,491+29.4%

€35,353,029+12.9%

€31,316,998+65.4%

€18,930,134

€4,332,361+18.2%

€3,666,339+43%

€2,563,271+26.2%

€2,031,458

€2,822,207+88.4%

€1,498,408-8.3%

€1,634,775+234.7%

-€1,213,504

€3,581,638

—

€2,508,973+63.8%

€1,531,618+16%

€1,320,097+190%

-€1,466,998

€198,887+88.1%

€105,763+0.4%

€105,351+373.8%

€22,235

Profitability

7.8%

—

5.5%+26.6%

4.3%+2.8%

4.2%+154.4%

-7.7%

60.3%-35%

92.8%-91.6%

1103.4%+802.9%

122.2%

12.2%+7.3%

11.4%+28.4%

8.8%+173.3%

-12.1%

Solvency

€20,595,819+52.7%

€13,490,171-9.7%

€14,934,396+22.9%

€12,156,341

€3,375,105+34.7%

€2,506,033+10.1%

€2,277,058+7.7%

€2,114,084

€39,424-17.9%

€48,008+3.2%

€46,519+15%

€40,461

€4,160,235+151.9%

€1,651,262>1000%

€119,644+110%

-€1,200,453

20.2%+65%

12.2%>1000%

0.8%+108.1%

-9.9%

€5,172,108+5.2%

€4,918,741+13.8%

€4,322,480+38.9%

€3,111,793

1.24-58.3%

2.98-91.7%

36.13>1000%

-2.59

€16,435,584+38.8%

€11,838,909-20.1%

€14,814,752+10.9%

€13,356,794

3.95-44.9%

7.17-94.2%

123.82>1000%

-11.13

24.51+54.5%

15.86+19.8%

13.24+138.6%

-34.33

Liquidity

€1,107,087-58.4%

€2,660,775+130.5%

€1,154,411+835.5%

€123,395

€6,529,154+30.2%

€5,014,874-27.3%

€6,896,302+35.3%

€5,098,743

€9,064,453+213.4%

€2,892,374-31.3%

€4,210,146-5.9%

€4,475,287

€9,994,725+60.9%

€6,212,977-37.6%

€9,956,935+17.1%

€8,505,132

€11,263,476+62.8%

€6,920,168-34%

€10,492,210+2.4%

€10,243,487

1.41+20%

1.18+8.9%

1.08+13.2%

0.96

€5,776,250+48.2%

€3,898,511+93%

€2,020,194+716.8%

-€327,541

Efficiency

72 days+142.2%

30 days-39.1%

49 days-43.1%

86 days

96 days+26.3%

76 days-43.8%

136 days-21.2%

172 days

72 days+0.1%

72 days-36%

112 days-9.4%

124 days

5.76+34.3%

4.29+14.4%

3.75+4.5%

3.59

Profit appropriation

-€13,318,734+15.9%

-€15,827,707+8.8%

-€17,359,325+7.1%

-€18,679,422

MEDIX Laboratoires N.V

Activities

Financials

Frequently asked questions

All locations

All locations